These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1601114)

  • 1. Preferential excretion of glycated albumin in C57BL-Ks-J mice: effects of diabetes.
    Kowluru A; Kowluru RA
    Experientia; 1992 May; 48(5):486-8. PubMed ID: 1601114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of glycated albumin in insulin-dependent diabetic patients with normal urinary albumin excretion.
    Pagano G; Chiambretti A; Calefato V; Tomalino M; Cecchini G; Bruno A; Cavallo-Perin P
    Acta Diabetol Lat; 1991; 28(1):39-45. PubMed ID: 1862690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The increase in albuminuria induced by exercise is not associated with preferential excretion of glycated albumin in type 1 (insulin-dependent) diabetic patients.
    Cavallo-Perin P; Chiambretti A; Calefato V; Tomalino M; Urbino R; Cecchini G; Pagano G
    Diabetologia; 1991 Nov; 34(11):813-6. PubMed ID: 1769440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with nephropathy.
    Cha T; Tahara Y; Yamato E; Yoneda H; Ikegami H; Noma Y; Shima K; Ogihara T
    Diabetes Res Clin Pract; 1991 Jul; 12(3):149-56. PubMed ID: 1889345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice.
    Cohen MP; Hud E; Shea E; Shearman CW
    Metabolism; 2002 Jul; 51(7):901-5. PubMed ID: 12077739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.
    Cohen MP; Masson N; Hud E; Ziyadeh F; Han DC; Clements RS
    Exp Nephrol; 2000; 8(3):135-43. PubMed ID: 10810230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycation of serum albumin and its role in renal protein excretion and the development of diabetic nephropathy.
    Bundschuh I; Jäckle-Meyer I; Lüneberg E; Bentzel C; Petzoldt R; Stolte H
    Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):651-6. PubMed ID: 1493158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal evaluation of the renal clearance of glycated albumin in the diabetic rat.
    Layton GJ; Allen TJ; Jerums G
    Diabetes Res Clin Pract; 1990 Mar; 8(3):221-6. PubMed ID: 2340793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of glycated albumin in end-stage renal failure: evidence for the principle of "physiological microalbuminuria".
    Donnelly SM
    Am J Kidney Dis; 1996 Jul; 28(1):62-6. PubMed ID: 8712223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of variation in turnover of glycated albumin on indices of diabetic control.
    Johnson RN; Easdale RW; Tatnell M; Baker JR
    Clin Chim Acta; 1991 May; 198(3):229-38. PubMed ID: 1889123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of changes in renal charge selectivity in patients with type 1 (insulin-dependent) diabetes mellitus.
    Kverneland A; Feldt-Rasmussen B; Vidal P; Welinder B; Bent-Hansen L; Søegaard U; Deckert T
    Diabetologia; 1986 Sep; 29(9):634-9. PubMed ID: 3792696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suggested mechanism for the selective excretion of glucosylated albumin. The effects of diabetes mellitus and aging on this process and the origins of diabetic microalbuminuria.
    Kowluru A; Kowluru R; Bitensky MW; Corwin EJ; Solomon SS; Johnson JD
    J Exp Med; 1987 Nov; 166(5):1259-79. PubMed ID: 3119757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.
    Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN
    J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
    Wang N; Xu Z; Han P; Li T
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin.
    Cohen MP; Hud E; Wu VY
    Kidney Int; 1994 Jun; 45(6):1673-9. PubMed ID: 7933815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.
    Cohen MP; Ziyadeh FN; Hong SW; Shearman CW; Hud E; Lautenslager GT; Iglesias-de la Cruz MC; Chen S
    Kidney Int; 2002 Jun; 61(6):2025-32. PubMed ID: 12028443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
    Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis.
    Meyer L; Chantrel F; Imhoff O; Sissoko A; Serb L; Dorey F; Fleury D; Smagala A; Kepenekian L; Krummel T; Le Floch JP; Kessler L
    Diabet Med; 2013 Nov; 30(11):1388-9. PubMed ID: 23909880
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
    Cohen MP; Chen S; Ziyadeh FN; Shea E; Hud EA; Lautenslager GT; Shearman CW
    Kidney Int; 2005 Oct; 68(4):1554-61. PubMed ID: 16164632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.